FG LpxC LUNG
Alternative Names: FG-PlxC LUNG; FGLpxC LUNGLatest Information Update: 20 Sep 2024
At a glance
- Originator Forge Therapeutics
- Developer Forge Therapeutics; Roche
- Class Antibacterials; Small molecules
- Mechanism of Action LpxC inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Gram-negative infections